APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01 Medical Dialogues Bureau27 Feb 2020 10:00 AM ISTVienna: APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, has...